ErbB2/Her2 Antibodies

Helsen, Hammill, Lau, Mwawasi, Afsahi, Bezverbnaya, Newhook, Hayes, Aarts, Bojovic, Denisova, Kwiecien, Brain, Derocher, Milne, Nelson, Bramson: "The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity." in: Nature communications, Vol. 9, Issue 1, pp. 3049, (2019) (PubMed).

Bielamowicz, Fousek, Byrd, Samaha, Mukherjee, Aware, Wu, Orange, Sumazin, Man, Joseph, Hegde, Ahmed: "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma." in: Neuro-oncology, Vol. 20, Issue 4, pp. 506-518, (2019) (PubMed).

Steele, Chakrabarti, Wang, Biesiada, Holokai, Chang, Nowacki, Hawkins, Mahe, Sundaram, Shroyer, Medvedovic, Helmrath, Ahmad, Zavros: "An Organoid-Based Preclinical Model of Human Gastric Cancer." in: Cellular and molecular gastroenterology and hepatology, Vol. 7, Issue 1, pp. 161-184, (2019) (PubMed).

Erlangga, Wolff, Poth, Peltzer, Nahnsen, Spielberg, Timrott, Woller, Kühnel, Manns, Saborowski, Vogel, Saborowski: "Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer." in: Cancers, Vol. 11, Issue 12, (2019) (PubMed).

Wang, Guo, Feng, Zhang, Xiao, Di, Chen, Zhang: "Single nucleotide variant profiles of viable single circulating tumour cells reveal CTC behaviours in breast cancer." in: Oncology reports, Vol. 39, Issue 5, pp. 2147-2159, (2018) (PubMed).

Li, Ma, Zheng, Zhang: "GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2." in: Journal of experimental & clinical cancer research : CR, Vol. 37, Issue 1, pp. 80, (2018) (PubMed).

Wang, Her, Hu, Chen, Tung, Wu, Hsu, Lee, Jin, Hwang, Chen, Huang, Liao: "ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 15, pp. E3129-E3138, (2018) (PubMed).

Scrima, Zito Marino, Oliveira, Marinaro, La Mantia, Rocco, De Marco, Malanga, De Rosa, Rizzuto, Botti, Franco, Zoppoli, Viglietto: "Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients." in: Journal of Cancer, Vol. 8, Issue 2, pp. 227-239, (2017) (PubMed).

Qi, Zhou, Lu, Yuan, Li, Wu, Huang, Shen, Zhao, Fu, Chu, Wang, Ren, Ma, Chen: "Development of a highly specific HER2 monoclonal antibody for immunohistochemistry using protein microarray chips." in: Biochemical and biophysical research communications, Vol. 484, Issue 2, pp. 248-254, (2017) (PubMed).

Seigel, Sharma, Hackam, Shah: "HER2/ERBB2 immunoreactivity in human retinoblastoma." in: Tumour biology, Vol. 37, Issue 5, pp. 6135-42, (2016) (PubMed).